Max Robotics — Global Service Robot Directory + US Certification

About

Aaron Delahanty is a pioneering figure in the field of organ-on-a-chip technology, with a focused expertise in creating automated, fluidically-coupled platforms that mimic human physiology. His major contributions center on the development of the "Interrogator," a robotic system that links multiple vascularized organ chips to enable complex, multi-organ experimentation. This work has been instrumental in moving from single-organ models to integrated "body-on-chips" systems, allowing for more accurate predictions of human pharmacokinetic responses to drugs. Delahanty’s 2020 paper on quantitative drug response prediction has garnered 463 citations, underscoring its profound impact on preclinical drug testing. His 2020 study on robotic fluidic coupling, with 401 citations, further established the scalability and reproducibility of these systems. Notably, his 2019 paper detailing the Interrogator platform—capable of automated culture, perfusion, and in situ imaging of up to ten organ chips—represents a foundational achievement in the field. Through these innovations, Delahanty has significantly advanced the potential to reduce reliance on animal models and accelerate drug development.